Algorithms in clinical decision tools have been making it harder for certain racial and socioeconomic groups to receive the healthcare they deserve.
17h
Insurance data can help fill gaps between longer medical trials for patients up against the clock
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...
Amid the current debate over the devastating impact of recent aid cuts on global health programmes, the question of ...
Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...
The American Society for Reproductive Medicine published a report that concludes preimplantation genetic testing for ...
Optimising RSV sample handling and laboratory workflows to support faster, more efficient clinical trial delivery.
World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...
Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...
The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...
Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they are not ready for the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback